Top Qs
Timeline
Chat
Perspective
Avatrombopag
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure.[8][9] It was approved for medical use in the United States in May 2018,[10][11] the European Union in June 2019,[7] and Australia in January 2023.[1]
It acts as a thrombopoietin receptor agonist.[12]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads